| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 173.23M | 176.97M | 224.41M | 200.99M | 148.58M |
| Gross Profit | 31.27M | 27.49M | 43.29M | 38.91M | 30.48M |
| EBITDA | 18.27M | 14.63M | 28.61M | 25.36M | 20.62M |
| Net Income | 7.55M | 4.17M | 16.72M | 13.79M | 8.55M |
Balance Sheet | |||||
| Total Assets | 164.95M | 168.27M | 174.06M | 174.43M | 165.19M |
| Cash, Cash Equivalents and Short-Term Investments | 17.39M | 15.56M | 32.53M | 35.57M | 35.74M |
| Total Debt | 2.15M | 2.13M | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 37.68M | 40.83M | 40.06M | 42.77M | 33.70M |
| Stockholders Equity | 127.27M | 127.44M | 133.99M | 131.66M | 131.50M |
Cash Flow | |||||
| Free Cash Flow | 10.18M | -7.62M | 10.96M | 13.66M | 6.02M |
| Operating Cash Flow | 24.02M | 12.14M | 20.55M | 19.86M | 10.40M |
| Investing Cash Flow | -14.07M | -18.06M | -8.98M | -6.20M | -3.97M |
| Financing Cash Flow | -8.12M | -11.04M | -14.61M | -13.83M | -6.78M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £143.47M | 19.35 | 3.83% | 6.69% | -2.11% | 81.02% | |
71 Outperform | £1.22B | 31.10 | 33.12% | 1.01% | 24.42% | 103.25% | |
67 Neutral | £208.46M | 29.31 | 6.13% | 1.02% | 3.36% | 63.32% | |
64 Neutral | £6.26B | 26.35 | 13.42% | 1.26% | 2.35% | -20.96% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | £1.21B | 22.50 | 8.58% | 3.30% | -3.96% | 192.10% | |
62 Neutral | £623.32M | 29.96 | 6.66% | 4.87% | -9.46% | -57.37% |